Getting Ahead of Disease Together

Getting Ahead of Disease Together

We unite science, technology and talent to prevent and treat disease β€” aiming to positively impact 2.5 billion people by 2030.

From world-leading vaccines to breakthrough specialty medicines, GSK is a global biopharma company with a purpose: to help people do more, feel better, and live longer.

Impact at Scale

Impact at Scale

We aim to positively impact the health of 2.5 billion people by the end of this decade through innovative science.

Prevention First

Prevention First

Our world-leading vaccine portfolio stops disease before it starts, protecting millions across every age group.

Focused R&D Innovation

Focused R&D Innovation

Cutting-edge immune system science and AI-powered drug discovery drive our pipeline across four therapeutic areas.

Responsible Access

Responsible Access

Ranked 2nd in the Access to Medicine Index, we ensure treatments reach patients who need them most worldwide.

Trusted by Leading Healthcare Institutions Worldwide

NHS England • Mayo Clinic • Johns Hopkins Medicine • Cleveland Clinic • MΓ©decins Sans FrontiΓ¨res • World Health Organization

Vaccines

Vaccines

Industry-leading vaccines for RSV, shingles, meningitis and hepatitis β€” protecting people at every stage of life.

Specialty Medicines

Specialty Medicines

Targeted therapies in oncology, immunology and HIV through ViiV Healthcare β€” advancing precision medicine.

General Medicines

General Medicines

Trusted respiratory inhalers and antibiotics supporting everyday health for patients around the globe.

R&D Pipeline

R&D Pipeline

Over 70 potential medicines and vaccines in development β€” powered by genetics, AI and immune science.

2.5 Billion β€” People We Aim to Impact
70+ β€” Pipeline Assets
2nd β€” Access to Medicine Rank
100,000+ β€” Employees Worldwide

Transformative Science

β€œGSK's RSV vaccine has been a game-changer for our older patients. We've seen a meaningful reduction in severe respiratory illness.”

Dr. Sarah Chen β€” Chief of Pulmonology, Mount Sinai Health

Advancing Access

β€œTheir commitment to equitable access is unmatched. GSK's global health programmes have reached communities other companies overlook.”

Dr. Amara Osei β€” Director, Global Immunisation Alliance

Innovation Culture

β€œJoining GSK was the best career decision I've made. The collaborative culture and investment in cutting-edge science is extraordinary.”

Dr. James Rivera β€” Senior Scientist, GSK R&D

Latest from GSK Insights

Explore the science, stories and breakthroughs shaping the future of healthcare β€” from vaccine innovation to the frontiers of oncology.

Ready to Get Ahead of Disease?

Ready to Get Ahead of Disease?

Partner with GSK to drive innovation in biopharma β€” from clinical trials to commercial collaboration.

Whether you are a healthcare professional, researcher or potential partner, discover how GSK can support your mission to improve patient outcomes worldwide.